Projects per year
Fingerprint
Dive into the research topics where Detlev Boison is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Targeting Adenosine Kinase for the Prevention of Post-Traumatic Epilepsy
Boison, D. (PI)
9/30/22 → …
Project: Research project
-
Therapies for Epilepsy Prevention - Focus on Adenosine
Boison, D. (CoPI) & Boison, D. D. (PI)
National Institute of Neurological Disorders and Stroke
7/1/22 → 6/30/26
Project: Research project
-
Targeting Adenosine Kinase for the Prevention of Post-Traumatic Epilepsy
Boison, D. (PI)
Congressionally Directed Medical Research Programs
1/1/21 → …
Project: Research project
-
Adenosine receptor mediated therapies for SUDEP
Boison, D. (CoPI) & Boison, D. D. (PI)
National Institute of Neurological Disorders and Stroke
9/15/18 → 6/30/23
Project: Research project
-
Adenosine kinase antisense gene therapy for temporal lobe epilepsy.
Boison, D. (CoPI) & Boison, D. (PI)
National Institute of Neurological Disorders and Stroke
4/1/15 → 3/31/16
Project: Research project
-
Adenosine Kinase: An Epigenetic Modulator and Drug Target
Peter-Okaka, U. & Boison, D., May 2025, In: Journal of Inherited Metabolic Disease. 48, 3, e70033.Research output: Contribution to journal › Review article › peer-review
Open Access2 Scopus citations -
Advances and challenges in experimental models of posttraumatic epilepsy for therapeutic interventions
Reddy, D. S., Golub, V. M., Ramakrishnan, S., Churn, S. B., Shapiro, L. A., Iannucci, J., Pitkänen, A., Galanopoulou, A. S., Maganti, R. & Boison, D., Sep 2025, In: Pharmacological Reviews. 77, 5, 100080.Research output: Contribution to journal › Review article › peer-review
Open Access1 Scopus citations -
Erratum to “Advances and challenges in experimental models of posttraumatic epilepsy for therapeutic interventions” (Pharmacological Reviews, (2025), 77, 5, (100080), (S0031699725074885), 10.1016/j.pharmr.2025.100080)
Reddy, D. S., Golub, V. M., Ramakrishnan, S., Churn, S. B., Shapiro, L. A., Iannucci, J., Pitkänen, A., Galanopoulou, A. S., Maganti, R. & Boison, D., Nov 2025, In: Pharmacological Reviews. 77, 6, 100099.Research output: Contribution to journal › Comment/debate › peer-review
-
Neuroglia and brain energy metabolism
Peter-Okaka, U. & Boison, D., Jan 2025, In: Handbook of Clinical Neurology. 209, p. 117-126 10 p.Research output: Contribution to journal › Article › peer-review
Open Access4 Scopus citations -
Neuropharmacology adenosine A2A receptor and glial glutamate transporter GLT-1 are synergistic targets to reduce brain hyperexcitability after traumatic brain injury in mice
Alves, M., Gerbatin, R., Kalmeijer, R., Fedele, D., Engel, T. & Boison, D., Nov 1 2025, In: Neuropharmacology. 278, 110599.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations